BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld Asia
Home
» In the clinic for March 29-April 4, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
In the clinic for March 29-April 4, 2022
April 5, 2022
No Comments
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adagio, Aldeyra, Arca, Ascletis, Atriva, Bio-Thera Solutions, Brii, Capricor, Cstone, Curevac, Glaxosmithkline, HDT, Immutep, Inflarx, Merck, Nrx, Recce, Revive, Ridgeback, Scancell, Vaxxinity, Zhimeng, Zhongze.
BioWorld Asia
Briefs
In the clinic